Paul Strickland Scanner Center Improves MR System For Prostate Cancer Patients

Paul Strickland Scanner Center Improves MR System For Prostate Cancer Patients
Independent medical charity Paul Strickland Scanner Center, part of the Mount Vernon Hospital, has launched the first MAGNETOM Prismafit in the United Kingdom as an upgrade to its MR system. The center is conducting a series of improvements in collaboration with Siemens Healthcare, which will be used to improve evaluation of next-generation oncology treatments, with a particular emphasis on prostate cancer. The charity center has partnered with the company in order to implement the MAGNETOM Prismafit system and improve its patients' results while reducing waiting time. The main purpose of offering the new system is to improve cancer therapies and the quality and life expectancy of cancer patients. In addition, the Paul Strickland Scanner Center is also planning on launching a MAGNETOM Avantofit upgrade. “The upgraded system is imaging between 12 and 15 patients per day," explained Anwar Padhani, the consultant radiologist and professor of cancer imaging at Paul Strickland Scanner Center in a press release. "Although we are using the Prismafit for all sorts of procedures such as oncological, brain and spinal imaging, the technology has been particularly valuable in our prostate cancer work.” “Recent guidelines implemented by NICE, London Cancer Alliance and BUPA for suspected prostate cancer now recommend MR scans should take place before invasive biopsy and call for active surveillance instead of more invasive treatments for non-aggressive disease,” added Padhani. The upgraded system is meant to provide a powerful 3T MRI platform and assist in the management of challenging MRI research. Prismafit consists of a XR 80/200 gradient system, the strongest gradient currently available, allowing the center to combine excellency gradients with
Subscribe or to access all post and page content.